Analysts say the dual announcements mean Quest and LabCorp likely did not have to resort to rock-bottom pricing to hold onto their agreements. » Read More
By: Angelica LaVito
Sunscreens don't last forever. Active ingredients, whether chemical or mineral, become less effective as they age. » Read More
Executives told Wall Street this week that they're interested in making money in the health space. » Read More
By: Angelica LaVito
The findings should encourage officials in these places to prepare so they're not scrambling if it spreads, said EcoHealth Alliance President Peter Daszak. » Read More
New Jersey has a new tick in town that is such an invasive pest, it does not need males to reproduce, according to a Rutgers University Assistant Professor of Entomology.
An ingestible micro-bio-electronic device has been developed at MIT that can detect blood in the stomach. It could end the need for endoscopy procedures.
AstraZeneca's immunotherapy drug Imfinzi has hit a second important goal by improving overall survival in lung cancer patients.
Point72's CEO of International Marc Desmidt explains which sectors the hedge fund is bullish on, as it expands its Asian operations.
Overshadowed by the opioid crisis, synthetic marijuana is a serious — and sometimes deadly — problem in America, according to US News & World Report.
A California jury on Thursday ordered Johnson & Johnson to pay $4 million in punitive damages to a woman who said she developed cancer after being exposed to asbestos in the company's baby powder.
Mylan is becoming increasingly frustrated with Pfizer's inability to tackle the shortage of the life-saving EpiPen, which has been placed on the FDA's official shortage list, the Financial Times reports.
Pfizer has agreed to pay $23.85 million to resolve U.S. government charges that it used a purportedly independent charity to pay kickbacks to Medicare patients.
In the wake of the E.coli romaine lettuce scare, Stop & Shop frozen broccoli is now being recalled due to listeria concerns, USA Today reports.
Medtronic reported a 25.5 percent rise in quarterly profit on Thursday on higher demand for its heart devices.
The increases come as President Donald Trump and congressional Republicans try to chip away at the Affordable Care Act, often referred to as Obamacare.
A new study is sounding the alarm about misuse of medication for attention deficit hyperactivity disorder, according to US News & World Report.
Twenty-somethings already have plenty to worry about — paying off student loans and saving for retirement. Here's why medical coverage belongs on that list of priorities.
Debt-ridden Teva is counting on the drug - fremanezumab - along with Huntington's treatment Austedo, to help it return to growth.
Merck said its cancer drug Keytruda helped extend survival and prevented disease progression when tested in a late-stage study in combination with chemotherapy for a type of lung cancer.
The U.S. State Department issued a health alert after a government employee stationed in China was diagnosed with a mild traumatic brain injury.